Objectives/Hypothesis: The premise of this study is that the membrane hypothesis of aging, also known as the mitochondrial clock theory of aging, is the basis for presbyacusis. Furthermore, it is proposed that treatment with antioxidants or dietary restriction can attenuate age-related hearing loss. Many studies have demonstrated a reduction in blood flow to specific tissues, including the cochlea, with aging. Hypoperfusion leads to the formation of reactive oxygen metabolites (ROM). ROM are highly toxic molecules that directly affect tissues including inner ear structures. In addition, ROM can damage mitochondrial DNA (mtDNA), resulting in the production of specific mtDNA deletions (mtDNA del 4977 [human] or mtDNA del 4834 [rat]; also known as the common aging deletion]. Previous corroborating data suggest that the common aging deletion mtDNA 4834 may be associated not only with aging but also with presbyacusis, thus further strengthening the basis of the current studies. In this study, experiments provide compelling evidence that long-term treatment with compounds that block or scavenge reactive oxygen metabolites attenuate age-related hearing loss and reduce the impact of associated deleterious changes at the molecular level. Study Design: Prospective randomized study. Methods: One hundred thirty rats were randomly assigned to one of six groups with appropriate controls. Animals were divided into the following treatment arms: group 1, 30% caloric restriction; group 2, vitamin E oversupplementation; group 3, vitamin C oversupplementation; group 4, melatonin treatment; group 5, lazaroid treatment; and group 6, placebo. In addition, 10 animals were used to determine the appropriate caloric restriction. All subjects underwent baseline and every-3-month testing until their health failed (range, 18 -28 mo; average, 25 mo). This testing included auditory sensitivity studies using auditory brainstem response (ABR) testing, as well as tissue analysis for mtDNA deletions using molecular biological techniques. At the conclusion of the study, animals underwent a final ABR test and were tested for mtDNA deletions in brain and inner ear tissues, and the opposite ear was used for histological analysis. Results: Results indicated that the 30%-caloricrestricted group maintained the most acute auditory sensitivities, the lowest quantity of mtDNA deletions, and the least amount of outer hair cell loss. The antioxidant-treated subjects had improved auditory sensitivities, and a trend for fewer mtDNA deletions was observed compared with the placebo subjects. The placebo subjects had the poorest auditory sensitivity, the most mtDNA deletions, and the greatest degree of outer hair cell loss. Conclusions: Intervention designed to reduce reactive oxygen metabolite damage appears to protect against age-related hearing loss specifically and aging in general. This is reflected by an overall reduction in mtDNA deletions. These data also suggest that the common aging deletion appears to be associated with presbyacusis, as demonstrated by an increased frequency of the mtDNA del 4834 in the cochleae with the most significant hearing loss. Nutritional and pharmacological strategies may very well provide rational treatment options that would limit the age-associated increase in ROM generation, reduce mtDNA damage, and reduce the degree of hearing loss as the organism advances in age.
INTRODUCTION
The premise of this study is that the membrane hypothesis of aging, also known as the mitochondrial clock theory of aging, is the basis for presbyacusis. This study expands on the fact that aged animals have a reduction in blood supply to the cochlea. It is hypothesized that this generalized hypoperfusion leads to the generation of reactive oxygen metabolites (ROM). The ROM damage mitochondria, manifesting as a reduction in mitochondrial membrane potentials and an increase in mitochondrial DNA (mtDNA) deletions with concomitant hearing loss. This study also demonstrate that long-term treatment with compounds that either block or scavenge reactive oxygen metabolites have a protective effect on age-related hearing loss and the associated alterations at the genomic level.
This study investigates new hypotheses designed to enhance the understanding of the molecular and biological mechanisms of presbyacusis. The primary purpose of these experiments was to determine whether the membrane hypothesis of aging has a fundamental role in ageassociated hearing loss. Furthermore, these experiments were designed to determine whether diet restriction and treatment with compounds known to reduce damage from ROM will affect the aging process in general, and presbyacusis in particular.
The process of aging is associated with many molecular, biochemical, and physiological changes including increases in DNA damage, reduction in mitochondrial function, decreases in cellular water concentration, ionic changes, vascular insufficiencies, and decreased elasticity of cellular membranes. One contributing factor to this process is altered vascular characteristics, such as reduced erythrocyte velocity and vascular plasticity, as well as increased vascular permeability.
1,2 These age-related changes result in reductions in oxygen and nutrient delivery, as well as waste elimination. 3, 4 Such functional alterations favor the production of ROM. In addition, there is support in the literature for an age-associated reduction in endogenous enzymes that protect from ROM damage, including superoxide dismutase, catalase, and glutathione peroxidase. 5 Collectively, these changes enhance the generation of ROM. ROM are responsible for producing mitochondrial DNA damage by causing mutations in the mitochondrial genome. Specific mutations are known to be directly proportional to aging, such as the common aging deletion in humans, which is 4,977 base pairs (bp) in length, and in rats (4,834 bp). When mtDNA deletions reach a certain level, the mitochondria become bioenergetically inefficient. Investigators have shown that aged rats, monkeys, and humans have reductions in mitochondrial function and increases in mtDNA deletions in heart, brain, liver, and skeletal muscle. 6 -8 To develop the basis for this study, the following topics are discussed: presbyacusis, reactive oxygen metabolites, mitochondrial function and mitochondrial DNA deletions, aging, and antioxidants.
HISTORICAL PERSPECTIVES AND REVIEW OF THE LITERATURE

Presbyacusis
"Biological aging appears to be a physiological process engendered by the genotype and the adaptive norm of the species. Superimposed on the inherited processes seems to be the gradual accumulation of errors in DNA, which is probably related to a decline in normal mechanisms of repair." Dr. Schuknecht displayed tremendous insight when he wrote these lines some two decades ago. That the concepts he had outlined remain relevant today is an affirmation of his stature as a scientist and clinician. Aging research has fortified these precepts as an accurate and meaningful perspective on senescence and its many manifestations, such as presbyacusis.
Presbyacusis is characterized by the progressive deterioration of hearing associated with aging and is the most common cause of adult auditory deficiency in the United States, affecting approximately 23% of the population between 65 and 75 years of age and 40% of the population older than 75 years of age. 9 Thus the socioeconomic ramifications are staggering. While presbyacusis is common in industrialized societies, age-related hearing loss is less pronounced in other societies. This discrepancy has been attributed to many factors, including genetics, diet, and socioeconomic and environmental factors.
10,11
Reactive Oxygen Metabolites or Free Oxygen Radicals
Reactive oxygen metabolites are species that contain an unpaired number of electrons making them chemically reactive and extremely toxic to cellular and subcellular structures. It has been speculated that ROM are involved in more than 100 clinical conditions. 12 They are produced in vivo during mitochondrial respiration, as well as via auto-oxidation of chemical and biological molecules. ROM are also environmental contaminants, can be formed from ionizing and ultraviolet radiation, and occur in response to hypoperfusion or ischemia followed by reperfusion.
There is extensive support in the literature for the protective effects of antioxidants and reactive oxygen metabolite scavengers. For example, tocopherols (vitamin E) decrease atherosclerosis and delay death from myocardial infarction, presumably by inhibiting lipid peroxidation. 13 Carotenoids, such as ␤-carotene and other plant pigments, may also have preventive effects against cancer and cardiovascular disease. 14, 15 Available data also suggest that many of the pathological correlates of Alzheimer's disease are precipitated by free radical-induced and oxidative stress-induced mechanisms. 16 Similarly, Parkinson's disease has also been associated with oxidative stress, increased lipid peroxidation, reduced levels of glutathione, high concentrations of iron, and free radical generation via autocatalytic mechanisms within neuromelanincontaining catecholaminergic neurons. 17 Experimentally and clinically, it is well known that a primary source of ROM generation is through oxidative phosphorylation, ischemia/reperfusion, or prolonged hypoperfusion, such as is seen in myocardial infarction, cerebrovascular accidents, aging, and, possibly, sudden sensorineural hearing loss and presbyacusis. It is clear that in the aging cochlea there is a significant reduction of blood supply 2 and the ongoing need for energy generation through oxidative phosphorylation. Thus these two processes allow for the generation of ROM within the cochlea.
Vascular Changes Associated With Aging
The aging process is clearly linked with alterations in circulatory function. Studies have demonstrated markedly decreased flow within the circulatory system in the elderly population. 3, 4 Prolonged periods of reduced blood flow
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Various lines of research have centered on the concept that altered blood flow and/or oxygen delivery results in inner ear hair cell damage and hearing loss. In a human cadaveric study of cochlear vessels, an age-related, gradual loss of capillaries in the spiral ligament of the scala vestibuli was observed, with an increase in intravascular strands and avascular channels. Similar but less pronounced findings were noted in the spiral ligament in the scala tympani. 18 Another human cadaver study, using a microsphere technique to quantify blood flow, found diminished flow in morphometrically normal-appearing basal turn capillaries. 19 Changes in whole blood viscosity and red blood cell rigidity have been correlated with highfrequency hearing loss in elderly humans. 20 Furthermore, a series of in vivo experiments using intravital microscopy of the cochlear microvasculature demonstrated agedependent, statistically significant reductions in mean erythrocyte velocity and significant increases in capillary permeability. 2 In contrast, Axelsson 21 noted no significant differences in cochlear blood vessels of young and old guinea pigs. However, there were more failures in contrast filling of the older animals' vessels, because of more frequent ruptures of the vessels. 21 It is possible that this may in part be due to increased vascular fragility that is a common feature of aged vasculature, a speculation endorsed by Dr. Axelsson. Furthermore, these findings may also be secondary to increased vascular permeability, which is a common sequela of ischemic injury.
Effects of Hypoxia on the Inner Ear
The effects of cochlear hypoxia on auditory function have been extensively studied. There is a direct correlation between hypoxia and decreased hearing sensitivity. Studies inducing hypoxia by inspiration of 100% nitrogen, 22 tracheal clamping and cessation of respiration, 23 and vessel occlusion 24 have all shown significant alterations of auditory sensitivity as measured by compound action potentials, summating potentials, cochlear microphonics, and otoacoustic emissions. 25, 26 Decreased blood flow from a variety of causes including hypertension, atherosclerosis, noise exposure, or aging promotes hypoxia with formation of ROM and resultant tissue/organ damage.
27,28
Mitochondrial DNA Deletions
Mitochondria are unique organelles possessing their own DNA as well as their own enzymatic constituents to allow for transcription and translation of genetic information into proteins. Each mtDNA codes for a complete set of ribosomal (rRNA) and transfer RNA (tRNA). In addition, mtDNA codes for 13 of the approximately 60 polypeptides necessary for oxidative phosphorylation. These include 7 of the 25 subunits of respiratory complex I (ND1-ND4, 4L, 5, and 6) (reduced nicotinamide adenine dinucleotide [NADH]-ubiquinol-oxidoreductase), 1 of the approximately 9 subunits (cyt b) of respiratory complex III (ubiquinol-cytochrome c oxidoreductase), 3 of the 13 subunits of respiratory complex IV (COI, COII, and COIII) (cytochrome c oxidase), and 2 of the 12 subunits of respiratory complex V (ATP6 and ATP8) (ATP synthase). The remaining subunits of these complexes are encoded by nuclear DNA. 29 It has been proposed that mitochondrial genomic mutations may be a major cause of human diseases. The first patient reported with a mtDNA deletion as a cause of illness was reported in 1959. 30 Luft is often credited with demonstrating the importance of mitochondrial medicine. 31 Mitochondrial mutations followed by cytoplasmic segregation has been shown to contribute to neuromuscular disorders such as Kearns-Sayre/chronic external ophthalmoplegia plus syndrome, 32 mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), 33 subacute necrotizing encephalomyopathies, SNE (Leigh syndrome) and progressive neuronal degeneration of childhood (Alpers syndrome), 34 and myoclonic epilepsy associated with ragged-red muscle fibers (MERRF). 29 Interestingly, as many as 67% of patients with mtDNA disorders are known to manifest sensorineural hearing loss. 35 Experiments performed since 1989 have demonstrated that mtDNA deletion with gene induction is also associated with hypoxia. Corral-Debrinski et al. 36 have found a specific mtDNA deletion occurring at increased frequency in ischemic hearts. They concluded that ischemic hearts have increased mtDNA damage and oxidative phosphorylation gene expression that may be associated with oxidative phosphorylation deficiency. In addition, there is evidence suggesting 5-to 12-fold elevations in mtDNA deletions in the brain associated with chronic hypoxia. 37 Deletions of mtDNA with subsequent segregation and enrichment of the deletions throughout life are contributing factors in the aging process. 6 It has been shown that mtDNA deletions in the human heart are age dependent. 6 Mitochondrial mutations occur and accumulate continuously until death. Cells that accumulate large numbers of mitochondrial mutations become bioenergetically deficient, which explains their important role in many human diseases. 38 Mitochondrial and nuclear DNA are exposed to a significant amount of oxidative damage. Studies have shown that increasing amounts of ROM occur as a function of age, which leads to an increase in membrane peroxide content and rapidly exceeds the capacity of homeostatic protection. 39 Thus there is extensive support that mtDNA deletions accumulate with age and disease. 40, 41 Deafness has also been shown to have an association with mtDNA deletions. It has been suggested that mitochondrial diseases should be considered in cases of progressive sensorineural hearing loss, especially with the coexistence of multisystem involvement. 42 A 10.4-kb mtDNA deletion has been identified in association with maternally transmitted diabetes and deafness, without ophthalmoplegia or mitochondrial myopathies, which was the hallmark of mtDNA deletion syndromes. 43 Other studies have identified mutations in the tRNA(Leu)(UUR) gene in a large pedigree with maternally inherited diabetes mellitus type II and deafness. 44 A 3,243-point mutation (A3 G) has been demonstrated in a patient with sensorineural deafness without diabetes. 45 Several
Laryngoscope 110: May 2000 Seidman: Presbyacusis human studies have demonstrated an association of mitochondrial DNA mutations and presbyacusis, including a study demonstrating that older patients with presbyacusis had a higher frequency of the common aging deletion (4,977 bp) compared with similar-aged patients without presbyacusis. 46 A significant difference in mtDNA deletion was noted in human archival temporal bones. Specifically, 14 of 17 aged patients with presbyacusis had the 4,977-bp deletion compared with 8 of 17 control patients with normal hearing.
47
Aging
Aging is the progressive accumulation of metabolic and physiological changes associated with an increasing susceptibility to disease. There are many hypotheses in the current literature providing explanations for senescence. Three of the most convincing theories are the telomerase theory of aging, the "dysdifferentiation" hypothesis of aging, and the membrane hypothesis of aging (also referred to as the mitochondrial clock theory of aging).
The telomerase theory of aging suggests that there is a reduction in telomere length over time. The end of a chromosome is made up of a structure called the telosome. The tip of the telosome is a region of DNA repeat sequences and associated proteins called the telomere. It is hypothesized that DNA transcription and replication are affected by position effects mediated by the telomere. Reduction in the length of the telomere and alterations in its chromatin assembly may explain the instability that occurs during senescence, as well as the immortalization process in vitro. 48 Although many aspects of telomerase activity remain undefined, it has been hypothesized that the balance between telomere shortening and telomerase activity underlies cellular aging processes.
The dysdifferentiation theory suggests that aging is a continuum of programmed differentiation leading to either a cessation of normal gene activity or a systematic activation of genes whose effects are deleterious to cellular function. Support for this theory is provided by apoptosis (programmed cell death) studies in hermaphroditic worms. These experiments elegantly elaborated the genetic mechanisms responsible for controlling cell death. The maintenance of homeostasis for cellular metabolism and function consumes a large fraction of total body energy expenditure. This is engineered by the delicate balance between cellular proliferation and death. For example, the Bcl-2 gene appears to prevent oxidative damage to cellular organelles and lipid membranes. 49, 50 Another protein that appears to operate as an accessory to Bcl-2 is a 21-kD protein referred to as Bax. The ratio between Bcl-2 and Bax appears to determine survival or death following an apoptotic stimulus. Specifically, elevated expression of Bcl-2 appears to be preventive, while that of Bax favors the apoptotic process. 49 The membrane hypothesis of aging states that aging is related to decreasing effectiveness of cellular protective and reparative mechanisms. This yields biochemical and metabolic errors, which progressively accumulate, resulting in cell death. 51 The hypothesis further postulates that cellular senescence is attributable to the cross-linking action of ROM within the cellular membrane. In addition, ROM lead to lipid peroxidation, polysaccharide depolymerization, nucleic acid disruption, and oxidation of sulfhydryl groups leading to enzyme inactivation. 52 Therefore the membrane hypothesis of aging suggests that ROMinduced cell membrane structural damage is the primary mediator in cellular aging. 53 Careful analysis of the above mechanisms suggests that certain aspects of the three leading theories of aging may be interrelated. That is, free radical species lead to genetic and cellular alterations resulting in cellular dysfunction and, consequently, senescence. It is even more intriguing to realize that a trigger for the Bax gene is ROM. 54 Thus a critical analysis of the prominent hypotheses of aging suggests that aspects of all three theories are likely to apply. Specifically, the generation of ROM damages cellular integrity, which may lead to alterations in gene expression, including telomere shortening and activation of Bax genes resulting in aging, apoptosis, and, ultimately, death.
Primary Treatment Interventions
The primary treatment interventions used in these experiments were the following:
Diet restriction. It is well known that a 30% caloric dietary restriction can enhance longevity by 30% to 50%. The putative mechanism is a reduction in metabolism and oxidation reactions and hence, a significant reduction in the generation of ROM.
Vitamin E. Vitamin E (tocopherol) is a potent fatsoluble antioxidant. The most active naturally occurring compound is RRR-␣-tocopherol. Polyunsaturated fatty acids (PUFAs) are liable to auto-oxidation. Each fatty acid free radical that is oxidized damages about three other PUFA molecules, thus producing a chain reaction that expands geometrically. Vitamin E can readily donate hydrogen atoms to terminate this chain reaction. The vitamin also appears to be essential for the protection of circulating lipoproteins and the correct functioning and stability of cell membranes.
Vitamin C. Vitamin C or ascorbic acid is a watersoluble vitamin. It cannot be endogenously synthesized in certain species, including humans; therefore its requirement must entirely be met by dietary intake. It is an effective scavenger for superoxide (O 2 .-), thiol (sulfurcentered), singlet O 2 , and hydroxyl radicals. It has been shown to recycle ␣-tocopherol in lipid membranes, thus delaying the onset of peroxidation in isolated human lowdensity lipoproteins (LDLs).
Melatonin. Melatonin (N-acetyl-5-methoxytryptamine) is an indole hormone primarily secreted by the pineal gland. Although primarily known for its effect on entrainment pathways of the biological clock and actions on photoperiodic time, melatonin is also an important neural antioxidant and free radical scavenger. It is believed to work via electron donation to directly detoxify free radicals such as the hydroxyl radical. In addition, melatonin has been found to protect cells (in vivo as well as in vitro) against oxidative damage induced by a variety of free radical-generating agents and processes. It is also effective in protecting nuclear DNA, membrane lipids, and, possibly, cytosolic proteins from oxidative damage. In addition, evidence suggests that it Laryngoscope 110: May 2000
Seidman: Presbyacusis enhances the defense capacity of many antioxidative enzymes such as superoxide dismutase, glutathione peroxidase, and nitric oxide synthase. Lazaroids. Lazaroids are 21-aminosteroids with no glucocorticoid, mineralocorticoid, or other hormonal properties. They are multimechanistic inhibitors of lipid peroxidation. Lazaroids scavenge free radicals and stabilize cell membranes by decreasing fluidity, preserving vitamin E content in these membranes, and increasing surface viscosity. They have demonstrated efficacy in improving neurological outcome after central nervous system trauma, subarachnoid hemorrhage, and ischemia.
MATERIALS AND METHODS
Fischer 344 rats were obtained from Harlan Inc. (Indianapolis, IN). A total of 130 2-month-old rats were used for these experiments. All procedures and protocols were reviewed and approved by the institution's Care for Experimental Animals Committee. All animal experiments were performed in a humane manner according to standards established by the National Institutes of Health (Bethesda, MD).
Subjects were maintained in individual cages at 21°C to 22°C with a 12:12-hour light-dark cycle initiated at 7:00 A.M. Food and water were available ad libitum to all groups with the exception of diet-restricted subjects.
To determine the appropriate dietary restriction, a group of 10 animals was originally studied for a period of 1 month. These 10 animals were placed in metabolic cages where strict caloric intakes and urinary and stool outputs were recorded. The animals ingested 16 g Ϯ 3 g of a standard rodent diet formulation per day. Thus the appropriate caloric restriction was calculated to be 11.2 g (30% restriction) of feed per day for the caloric-restricted group.
The remaining 120 rats were randomly assigned to one of the following six groups: group 1: 30% caloric restriction (n ϭ 20); The subjects were initially anesthetized using ketamine and xylazine (100 mg/kg and 15 mg/kg, respectively, intramuscularly) and supplemented with ketamine as required.
To simplify identification of each individual rat and to eliminate the possibility of inadvertently misidentifying the subject, an electronic identification (ID) microchip (Avid, Norco, CA) was inserted into each animal and read with a scanner before any testing or treatment. In brief, the posterior nuchal region was prepared and draped in a sterile manner. A 3-mm incision was made posteriorly, and the ID microchip inserted. The wound was closed with an interrupted 4-0 Vicryl suture.
After the microchip insertion, a separate incision was made immediately cephalad to the microchip incision and the appropriate pellet (per previous randomization) was inserted into the subcutaneous tissues. This wound was closed with one 4-0 Vicryl suture. The pellets were purchased from Innovative Research (Sarasota, FL). The pellets have been tested extensively to verify stated timed-release parameters, appropriate dosing, and appropriate blood levels. The pellets selected for these experiments were 3-month pellets and were guaranteed to provide basal levels of the particular drug or vitamin throughout the entire time course.
Drug Dosages
Dosages of drugs used were as follows: vitamin E, one pellet implanted with 222.75 mg vitamin E, each delivering 2.475 mg/d; In addition, random assays were performed on animals to determine blood levels of vitamin E and melatonin groups at three separate time points during the life of the pellet. The technique to perform the assays used high-pressure liquid chromatography.
Auditory Brainstem Response Measurements
Auditory brainstem response (ABR) measurements were collected every 3 months from 2 months of age until the death of the animal. Each ear was studied for auditory sensitivity. Subjects were anesthetized using ketamine and Rompun (100 mg/kg and 15 mg/kg, respectively, intramuscularly) and supplemented with ketamine as required. The subject's temperature was maintained at 38°C Ϯ 1°C with a heating blanket and monitored with a rectal probe.
Signal generation. The test stimulus consisted of tonebursts with a rise/fall time of 1 millisecond, a duration of 15 milliseconds, and a period of 100 milliseconds. Intensity series were obtained at 3, 6, 9, 12, and 18 kHz, ranging from 0 dB sound pressure level (SPL) to 100 dB SPL. These stimuli were generated using a digital-to-analogue converter (model DA3-2, Tucker Davis Technologies, Gainesville, FL). The output of the digitalto-analogue converter was connected to a programmable attenuator (model PA4,Tucker Davis Technologies), a weighted summer (model SM3, Tucker Davis Technologies), a headphone buffer (model HB6, Tucker Davis Technologies), and an earphone (model DT-48, Beyer Dynamic, Heilbronn, Germany) that was placed in close approximation to the tympanic membrane of the animal. A sampling frequency of 100 kHz was used to generate the signal. The signals were calibrated at the tympanic membrane using a probe microphone (model ER-7C, Etymotic Research, Elk Grove Village, IL). The output of the microphone was connected to an analogue-to-digital converter (model AD2, Tucker Davis Technologies) and a Pentium computer. An automatic calibration routine was used for on-line calibration.
Recording. Sterile platinum needle electrodes (model E2, Grass Instruments, Quincy, MA) were placed under each pinna and at the vertex of the subjects (under anesthesia). The electrodes were connected to a biological amplifier (model P5 series, Grass Instruments) with the gain setting at ϫ 100,000. The response was filtered between 0.3 and 3 kHz. The output of the amplifier was connected to an analogue-to-digital converter (model AD2, Tucker Davis) and a Pentium computer. The responses were digitized with a sampling frequency of 50 kHz. For each recording, a 20-millisecond neural response was averaged 1,024 times. Thresholds were identified when an N1 response 1 V above baseline was observed, using a standard protocol.
Isolation of Intact Mitochondria From Muscle Samples
Isolation of mitochondria from muscle was performed as previously described. 55 In brief, the muscle specimen, weighing approximately 1 g, was freed of any fat or connective tissue and rinsed in cold, nonionic isolation buffer containing 210 mmol/L mannitol, 70 mmol/L sucrose, 1 mmol/L ethyleneglycol-bis-(betaaminoethylether)-N,N,NЈ,NЈ-tetra-acetic acid (EGTA), 0.5% BSA, and 5 mmol/L N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES), pH 7.2. The specimen was processed in approximately 0.5-g batches with a Thomas (Thomas Scientific, Swedesboro, NJ) tissue slicer. The thinly sliced muscle was collected into a 50-mL tube, suspended in 10 mL isolation buffer/g muscle tissue. The muscle tissue was homogenized using 10 passes in a Laryngoscope 110: May 2000
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Teflon-glass homogenizer with moderate rotation speed. The resulting sample was centrifuged at 1500 ϫ g for 5 minutes at 4°C. The supernatant was decanted into a fresh tube, the pellet was discarded, and the sample underwent repeat centrifugation. The supernatant was decanted and centrifuged at 8000 ϫ g for 15 minutes. The mitochondrial pellet was suspended in 30 mL isolation buffer and centrifuged again at 8000 ϫ g for 15 minutes. The washed mitochondrial pellet was resuspended in 0.1 mL of the isolation buffer for each gram of muscle used. This sample could then be stored at Ϫ70°C. For protein estimation, a 30-L aliquot was removed and centrifuged at 8000 ϫ g for 15 minutes, and the pellet was resuspended in isolation buffer without BSA.
Tissue Sources
The tissues harvested from the animal subjects included brain, auditory nerve, and stria vascularis. All tissues were used immediately or stored at Ϫ70°C for later use.
DNA Extraction
Animal tissues were harvested and stored at Ϫ70°C, until the time of DNA extraction. The samples were homogenized in 10 mmol/L Tris (pH 8) containing 1 mmol/L EDTA buffer and incubated overnight at 56°C with 15 L Proteinase-K (10 mg/mL) in 0.5 mL digestion buffer consisting of 10 mmol/L Tris (pH 8), 10 mmol/L EDTA, 50 mmol/L NaCl, and 2% sodium-dodecyl sulfate. Standard extraction protocols for DNA were used with phenol, chloroform, and isoamyl alcohol. The proteins were removed from the sample solution with phenol and chloroform, (25:24) both of which served as separate organic solvents and hence deproteinized more efficiently. The tissue extracts were centrifuged at 10,000 ϫ g at room temperature to separate mtDNA from cellular debris and protein. The supernatant was drawn off, and the residual phenol removed with equal volumes of chloroform and isoamyl alcohol (24:1). This subsequent extraction with chloroform removed the remaining traces of phenol from the preparation. A 1/10 volume of 3 mol/L NaOAc and 1/100 volume of 1 mol/L MgCl 2 were added, and mtDNA was recovered by precipitation with 2 volumes of cold ethanol. This preparation was stored at Ϫ70°C for 60 minutes, and the precipitate was recovered by centrifugation at 12,000 rpm for 30 minutes (4°C). The supernatant was removed, and the pellet washed with 70% ethanol, air-dried, and redissolved in Tris-Edta buffer at the desired concentration. DNA concentrations were determined spectrophotometrically using optical densities of 260 and 280 nm, and aliquots were used for polymerase chain reaction (PCR).
There are technical differences in isolating DNA from skeletal muscle compared with other tissues. The methodology necessitates special attention for the isolation of tightly coupled mitochondria. Our laboratory has used the modifications as previously described.
56
Polymerase Chain Reaction
Oligonucleotide primers were designed in our laboratory and synthesized by Fisher Biotech (Pittsburgh, PA) to amplify several distinct regions of the rat, mouse, and human mtDNA genome. Of particular interest is the cytochrome b gene, the ND1 segment of the 16S rRNA region and a 4,834-bp deletion in rats. PCR is used to amplify the base-pair products that correspond to these regions. Appropriate positive and negative controls were run and then sequenced to authenticate the PCR products. 
Gel Electrophoresis
The amplified PCR products were separated by electrophoresis on 1.5% agarose gel containing ethidium bromide. The gels were read under ultraviolet light and imaged. Agarose gel concentrations vary depending on fragment length. Thus for larger fragments a 1% agarose gel was used.
DNA Sequencing
Details of sequencing have been described previously. 57 The age and, possibly, presbyacusis-dependent mtDNA region was selectively amplified, and the resulting fragment was gel purified. Asymmetric PCR was performed with primers at a 1:100 ratio. A direct sequencing of the single-stranded mtDNA was made by asymmetric PCR using the "fmol" DNA Sequencing System (Promega Co., Madison, WI).
Histology
Subjects were deeply anesthetized. Cardiac puncture was performed, and the animal was perfused with 2.5% glutaraldehyde solution in a veronal acetate buffer freshly normalized to a pH of 7.4. The bullae were rapidly removed, and the cochleae were reperfused through the oval and round windows. The cochleae were stored at 4°C for 48 hours, then perfused with 1% osmium tetroxide in veronal acetate buffer normalized to a pH of 7.4 for 30 minutes. After perfusion, the organs were dehydrated using ethanol of ascending strength from 30% to 70%. The cochleae were decalcified overnight in 0.35 mol/L of EDTA in veronal acetate buffer normalized to a pH of 7.4 at room temperature. After decalcification, the organ of Corti was dissected in 70% ethanol. Each turn was mounted with glycerol and examined under an optical microscope. The hair cells were counted at original magnification ϫ 630, using a Carl Zeiss GFL (Carl Zeiss Inc., Goettingen, Germany) differential interference contrast microscope. The data were used to generate cytocochleograms as a frequency position map based on the following mathematical derivation:
where F stands for frequency, A ϭ 0.64, a ϭ 2.1, x is expressed as a proportion of basilar length, and k ϭ 0.85.
Statistical Methodology
Outcome variables. The hearing levels for five frequencies (3, 6, 9, 12, and 18 kHz) were tested separately.
Multiple comparisons. A Bonferroni adjusted P value of .01 (P ϭ .05/5) was used to determine statistical significance for each overall test for a treatment group effect for the five frequencies. If the overall test was not significant, tests between individual treatment groups were not performed. If the overall test was significant, comparisons between treatment groups, two at a time, were performed and a P value of .05 or less was considered statistically significant.
Analysis methods. To compare the baseline, pretreatment values, one-way ANOVA was performed. To make use of serial observations, repeated-measures analysis was performed using the SAS PROC MIXED 58 procedure. The model assumed a correlation between observations that decreased with the time (i.e., a lower correlation between the observations at months 15 and 25 compared with those between months 15 and 20 or between months 20 and 25). The PROC MIXED procedure allows subjects to be included even if observations are not available for all times.
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The model included an adjustment for the average levels observed at each month. Four analyses were performed. These were restricted to all data available at 25 months, all data from 20 months onward, all data from 15 months onward, and all data from 12 months onward. The data from the oldest animals were of greatest interest, but earlier data were also included.
RESULTS
This randomized prospective study was completed over a 3-year period. A total of 120 subjects were initially tested, and all subjects were studied throughout their life span. At the conclusion of the experiments, there were five animals available for analysis in the diet-restricted group (mean age, 27 mo), four in the vitamin E group (mean age, 26 mo), four in the vitamin C group (mean age, 24.5 mo), three in the melatonin group (mean age, 25 mo), three in the lazaroid group (mean age, 26 mo), and three in the placebo group (mean age, 26).
Blood Levels of Vitamin E and Melatonin
To verify the appropriate functioning of the matrix drug delivery system, serum for vitamin E and melatonin testing was obtained. Other assays are available for the remaining treatment options, but they are considered unreliable and extremely expensive. Testing was performed at four separate time points: at baseline, 1 week after implantation of the 90-day pellet, 6 weeks after implantation, and just before the pellet was due to be changed (85-89 d). Levels of the supplemented vitamin or hormone were in the appropriate range.
The vitamin E group baseline levels were 9 Ϯ 0.5 nmol/mL. The levels at 1 week, 6 weeks, and just before pellet change were 16.4 nmol/mL Ϯ 1.7 nmol/mL. Melatonin levels are subject to diurnal variation. Testing was performed at approximately 10:00 A.M. and revealed a baseline level of 59.5 pg/mL Ϯ 5 pg/mL. The levels at 1 week, 6 weeks, and just before pellet change were 1,446 pg/mL Ϯ 145 pg/mL.
Auditory Sensitivity Results
Baseline auditory thresholds for all subjects at 2 to 4 months of age were in the range of previous studies in our laboratory as well as other laboratories, and were between 15 and 35 dB in the frequencies tested. Over the span of 24 to 27 months the thresholds shifted the least in the dietrestricted groups and the treated subjects. The threshold shifted the most in the placebo group as tested at 26 months. The difference between the restricted-diet group and the placebo group was statistically significant (P Ͻ .01). The antioxidant-treated groups had a statistically significant protective effect when compared with the placebo group, but this effect was frequency specific (P Ͻ .05). In other words, not all frequencies showed a statistically significant response. Specifically, the vitamin E group experienced statistically better auditory thresholds at 6, 9, and 12 kHz (P Ͻ .05), but not at 3 or 18 kHz. Vitamin C-treated animals showed a statistically significant lower threshold compared with the placebo group at all frequencies except 3 kHz. Melatonin results were statistically better than placebo results at all frequencies except 12 kHz. Lazaroid was better than placebo only at 12 kHz.
There was a progressive reduction of auditory sensitivity which began at approximately 6 to 9 months of age in all groups. The greatest amount of hearing loss occurred over the last 12 months of life. The least amount of presbyacusis was observed in the diet-restricted subjects. The other treated animals experienced better hearing sensitivities than the control group, and this was statistically significant for all groups (P Ͻ .01) with the exception of the lazaroid group, and the overall effect varied with frequency. Figure 1 is a graph depicting cumulative audiological data of all groups. Table I summarizes the tests for overall treatment effects for each of the four analyses. The first four frequencies showed significant treatment effects in all of the analyses. A treatment effect could not be confirmed for a frequency of 18 kHz for the two analyses restricted to animals observed for 20 months or more.
The means for the various groups and the results of the comparisons between groups within the repeatedmeasures analysis are available in the detailed thesis (unpublished data).
Mitochondrial DNA Deletions
To study changes in mitochondrial DNA, we evaluated brain, auditory nerve, and stria vascularis for cytochrome b, the ND-1 16S rRNA region of the mitochondrial genome and the common aging deletion (mtDNA 4834 ). Cytochrome b and ND-1 16S rRNA are used as controls to verify the presence of mitochondrial DNA while the mtDNA 4834 is the test of interest that provides a molecular marker of aging. All specimens were positive for cytochrome b and ND-1 16S rRNA, verifying the presence of mtDNA. A small piece of muscle was harvested at every 3-month testing interval, thus allowing the opportunity to determine when the deletion was first apparent. The common aging deletion gradually appeared at 9 months of age in all groups except the restricted-diet group. This group did not show evidence of the common aging deletion until 16 months of age. Quantification studies revealed an ageappropriate increase in the mtDNA 4834 , and DNA sequencing verified the authenticity of the PCR products. The most rapid accumulation of the mtDNA 4834 was evident in the ad libidum diet (placebo); the other treated groups had a slower accumulation of the deletion (Figs.  2A-C) .
Histology
The histological results demonstrated loss of outer hair cells that is typically observed with aging. The differences between the groups showed less hair cell loss in the restricted-diet group and a slight reduction in hair cell loss in the treated animals as compared with the control subjects. Fig. 3A and B shows cochlear histograms from the diet-restricted and placebo groups, respectively.
DISCUSSION
The results of this prospective study demonstrate that with the normal aging process (the placebo group) there is a progressive reduction in auditory sensitivity Laryngoscope 110: May 2000
Seidman: Presbyacusis similar to presbyacusis observed in humans. This reduction in hearing accelerates during the last 12 months of life. Furthermore, there is an age-appropriate accumulation of the common mtDNA deletion. This progression of age-related hearing loss and accumulation of mtDNA deletions can be attenuated by long-term treatment with antioxidants and scavengers of ROM. The findings observed in the histological results are a bit more difficult to interpret, but overall, they support these conclusions. Presbyacusis or age-related hearing loss is the leading cause of hearing loss in the world, creating a significant burden not only for the sufferers, but also for those who communicate with them. The medical and socioeconomic costs are staggering, and with the expansion of the world population and the numbers of elderly individuals expecting to more than double by the year 2030, this problem is escalating.
There is significant evidence supporting the concept that altered blood flow and/or oxygen delivery results in hair cell damage. Atrophy of striae has been reported in elderly human cadavers, even in the absence of classic atherosclerotic changes. 18 Similar changes have been identified in the stria vascularis of gerbils. 59 Prazma et al. 19 have observed diminished flow in capillaries of the basal turn of the cochlea, and blood viscosity and red blood cell rigidity appear to correlate with high-frequency hearing loss in elderly human subjects. 20 A relationship between vascular atrophy and presbyacusis has been proposed. 60 In addition, studies have demonstrated a significant reduction in erythrocyte velocity, increased vascular permeability, a trend for reduced capillary diameters, and a decrease in auditory sensitivity with aging. 2 Thus genetics, dietary factors, and environment have been suspected to play a pivotal, yet poorly defined, role. The current experiments support previous literature and expand on earlier findings by observing the progression of Fig. 1 . Auditory thresholds of the tested groups at the last auditory brainstem response (ABR) recording across all five frequencies. The X-axis plots frequency; the Y-axis plots decibels. age-related hearing loss in a prospective randomized trial. Furthermore, the identification of significant protection of auditory thresholds in the diet-restricted groups and the partial protection observed in the treated subjects in comparison with the placebo group support the hypothesis of this proposal; specifically, diet restriction, which reduces the formation of ROM, and antioxidants, which attenuate age-associated hearing loss. Representative animal cochlea from a placebo subject (original magnification ϫ 400). Note the three outer hair cell rows (1, 2, 3 ). There are many hair cells missing, which correlates well with the severe-profound hearing loss noted on ABR testing.
This report represents the first prospective randomized study designed to investigate the effect of antioxidants, nutritional supplementation, and dietary restriction on hearing loss specifically and on aging in general. Furthermore, these studies propose that the mechanism involving the generation of ROM and resultant damage to mitochondria may be responsible in part for presbyacusis.
The observations from this study that dietary restriction and other nutrient supplementation reduce the progression of age-related hearing loss is an important initial step toward outlining strategies that may slow the progression of presbyacusis. All of the interventions used affect the generation of ROM.
There is an increasing body of evidence implicating ROM in the damage associated with cochlear ischemia, noise trauma, aging, presbyacusis, and ototoxicity. Specifically, localized inner ear ischemia and hypoxia induced via selectively clamping the anterior inferior cerebellar artery normally abolishes the compound action potential within seconds and the effect becomes permanent after 8 minutes of ischemia. When subjects were pretreated with allopurinol or superoxide dismutase followed by ischemia, compound action potential thresholds were maintained. 61 In addition, these experiments were extended to study noise-induced hearing loss, which, like aging, has also been shown to cause vascular perturbations.
Despite the potential for prevention of some of these disorders using antioxidants, there are other studies which have not demonstrated a benefit of treatment using antioxidant compounds such as superoxide dismutase (SOD) 62, 63 and ␣-tocopherol. 64 Critical analysis of these negative studies reveals several flaws ranging from insufficient statistical power to lack of appropriate controls, use of the wrong conjugates of SOD (i.e., those with a short half-life of 1-4 s), and design difficulties. For example, one study gave SOD 8 hours after closed-head injury, when the majority of the damage had already occurred. 62 There is a significant body of literature providing evidence that oxidative damage is important in the aging process. It has been demonstrated that life span differences in certain rodent and primate species depend in part on free radical scavenging systems. Investigators observed that animals with longer life spans had higher levels of SOD activity. 65 Many studies have investigated dietary increases in antioxidants and have demonstrated life span increases of 13% to 30%. 66, 67 Metabolic rate is also closely linked to the aging process. Many investigators have shown an inverse relationship between metabolic rate and life span. 68, 69 The relationship between aging and metabolic rate is clear because the production of toxic oxygen radicals is proportional to the rate of oxygen utilization (i.e., the metabolic rate), and this has a close direct relationship with dietary intake. Collectively, these studies provide both indirect and direct evidence that ROM are responsible for many clinical diseases including cochlear damage from ischemia, noise, and, possibly, aging.
The results of the mitochondrial experiments clearly demonstrate the highest amount of the common aging deletion in the placebo subjects with the least numbers of deletions observed in the diet-restricted group. There was a trend showing fewer deletions in the treated groups compared with placebo. Given the long-term effect of damage to cells and tissues exposed to the normal amounts of ROM, the findings of protection in auditory sensitivity and mtDNA deletions are encouraging.
The results of this study clearly demonstrate a protective effect of dietary restriction and nutritional oversupplementation on age-related hearing loss and mtDNA deletions. This beneficial effect most likely represents a slowing of the mitochondrial clock theory of aging. Specifically, dietary restriction and other mechanisms aimed at reducing the overall burden of ROM provide an internal milieu that is more favorable to the organism. The findings support that the other treatment arms were protective overall. Vitamins E and C, melatonin, and lazaroid appear to offer at least a partial protective effect. This effect is not as evident as with dietary restriction. This limited benefit may be explained in part by the fact that each animal was oversupplemented with individual compounds. There is compelling evidence that supplementing with only one antioxidant may not be as effective as supplementing with multiple antioxidants. This makes teleological sense when considering that nutritional antioxidants work by a variety of mechanisms. Some stabilize cell membranes, others scavenge ROM molecules, yet others enhance the role of other antioxidants. However, in experimental design, it is crucial to test supplements individually, first, to elucidate specific properties and effects. Based on such experimentation, studies subsequently can be designed to observe the effect of supplements in combination. Indeed, experiments to investigate such a combined effect have clearly shown a synergistic positive effect on generalized system function. 70 Furthermore, ongoing studies in our laboratory are addressing this specific issue using a combination of vitamins and compounds that can enhance mitochondrial function.
CONCLUSION
This study presents empirical evidence in support of an integrated hypothesis of aging and presbyacusis. In addition, presented data provide a framework for the continuing identification and evolution of pharmacological and nutritional strategies designed to attenuate ageassociated hearing loss. Areas of scientific inquiry have also been identified that require further investigation with the ultimate goal of enhancing our understanding of the mechanisms that surround senescence, both as a phenomenon and as an intrinsic biological property.
